ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1714

Young Patients with Back Pain and Maximally 1 Spa Feature: Is It Useful to Test HLA-B27 or Image the Sacroiliac Joints?

Pauline Bakker1, Zineb Ez-Zaitouni2, Miranda van Lunteren2, Manouk de Hooge3, Rosaline van den Berg4, Inger Jorid Berg5, Robert B. M. Landewé6, Maikel van Oosterhout7, Roberta Ramonda8, Monique Reijnierse9, Floris van Gaalen1 and Désirée van der Heijde10, 1Rheumatology, Leiden University Medical Center, Leiden, Netherlands, 2Leiden University Medical Centre, Leiden, Netherlands, 3Department of Rheumatology, Leiden University Medical Centre, Leiden, Netherlands, 4Leiden University Medical Center, Leiden, Netherlands, 5Department of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway, 6Rheumatology, University Hospital Maastricht, Maastricht, Netherlands, 7Rheumatology, GHZ Hospital, Gouda, Netherlands, 8Cattedra, Voc Rheumatology, University of Padua, Padova, Italy, 9Radiology, Leiden University Medical Center, Leiden, Netherlands, 10University Hospital, Maastricht, Netherlands

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: classification criteria and spondylarthritis, Diagnostic Tests

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 9, 2015

Title: Spondylarthropathies and Psoriatic Arthritis - Comorbidities and Treatment Poster II

Session Type: ACR Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose:
Axial SpondyloArthritis (axSpA)
is a heterogeneous disease. The likelihood of diagnosis varies depending upon
the specific findings that are present. However, it is debated whether
additional examinations (i.e. HLA-B27 testing and imaging of the sacro-iliac joints (SIJ)) should be performed in patients
with a low suspicion of axSpA: i.e. negative findings
on medical history, physical examination, CRP/ESR measurement. By this study we
aim to investigate if HLA-B27 testing and imaging of the SIJ is useful in young
patients with back pain and maximally 1 SpA feature.

Methods:
The SPACE cohort includes patients with chronic back pain (≥3 months
≤2 years, onset <45 years) recruited from 6 participating centres
across Europe. All patients underwent full diagnostic work-up: MRI and x-rays
SIJ, HLA-B27 testing and assessment of all other SpA-features.
Patients were classified according to the ASAS axSpA-criteria.

Results:
In this analysis, 133 patients from 4 participating centres were included. Of
the 38/133 (28.6%) patients with 0 SpA-features; 4/38
(10.5%) were classified according to the ASAS-axSpA
criteria after additional investigations (imaging arm only: 2MRI+/mNY+, 1MRI+/mNY-,
1MRI-/mNY+). Of the 95/133 (71.4%) patients with 1 SpA-feature; 22/95 (23.2%)
patients fulfilled the ASAS-axSpA criteria (imaging
arm only: 3MRI+/mNY+, 15MRI+/mNY-, 4MRI-/mNY+). Those patients presented the
following features: 7 IBP, 5 IBD, 4 positive family history for SpA, 3 good
response to NSAIDs, 2 raised CRP/ESR, 1 enthesitis.

Conclusion:
In patients with CBP and 0 or 1 SpA-feature after
medical history, physical examination and CRP/ESR measurement, subsequent
HLA-B27 testing and imaging led to fulfilment of the axSpA-criteria
in 11% and 23% respectively. Therefore in these patients, the disease cannot be
ruled out without additional imaging and/or HLA-B27 testing.

Table 1:
classification and diagnosis of patients with 0 and 1 SpA-feature
after HLA-B27 and SIJ-imaging

No. of SpA-features

HLA B27 status

Imaging status

ASAS axSpa YES

Rheum

Spa YES

ASAS axSpA NO

Rheum SpA NO

0

B27 +

MRI+mNY+

2

2

–

MRI+mNY–

1

1

–

MRI-mNY+

1

–

1

MRI-mNY-

–

2

3

1

B27 –

MRI+mNY+

–

–

MRI+mNY–

–

2

5

2*

MRI-mNY+

–

–

MRI-mNY-

–

26

26

1

B27 +

MRI+mNY+

2

–

1*

MRI+mNY–

4

3

–

1

MRI-mNY+

1

–

*

MRI-mNY-

–

2

15

12*

B27 –

MRI+mNY+

1

1

MRI+mNY–

11

8

3

MRI-mNY+

3

2

1

MRI-mNY-

–

1

58

57

Total

26

24

107

105


Disclosure: P. Bakker, None; Z. Ez-Zaitouni, None; M. van Lunteren, None; M. de Hooge, None; R. van den Berg, None; I. J. Berg, None; R. B. M. Landewé, None; M. van Oosterhout, None; R. Ramonda, None; M. Reijnierse, None; F. van Gaalen, None; D. van der Heijde, None.

To cite this abstract in AMA style:

Bakker P, Ez-Zaitouni Z, van Lunteren M, de Hooge M, van den Berg R, Berg IJ, Landewé RBM, van Oosterhout M, Ramonda R, Reijnierse M, van Gaalen F, van der Heijde D. Young Patients with Back Pain and Maximally 1 Spa Feature: Is It Useful to Test HLA-B27 or Image the Sacroiliac Joints? [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/young-patients-with-back-pain-and-maximally-1-spa-feature-is-it-useful-to-test-hla-b27-or-image-the-sacroiliac-joints/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/young-patients-with-back-pain-and-maximally-1-spa-feature-is-it-useful-to-test-hla-b27-or-image-the-sacroiliac-joints/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology